First-in-human SAD & MAD trials for MW151, a novel Alzheimer's disease drug candidate that attenuates proinflammatory cytokine dysregulation

Project: Research project

Project Details

StatusFinished
Effective start/end date2/1/1911/30/23

Funding

  • University of Kentucky (3200002345-19-178 // 1R01AG061898-03)
  • National Institute on Aging (3200002345-19-178 // 1R01AG061898-03)